News & Trends

• 27 2022-05

  Updated progress of Allisartan Isoproxil and Inda...
• 24 2022-05

  Salubris Biotherapeutics Announces New Pipeline Ad...
• 09 2022-03

  Salubris Biotherapeutics Announces $32 Million Fin...
• 04 2022-03

  NMPA Approves Clinical Trials with SAL0114 Tablets...
• 14 2021-01

  Significant progress has been made in the applicat...

  Recently, Salubris received the Notice of Approval of Clinical Trials approved and issued by National Medical Products Administration, which means tha...